国际眼科杂志
國際眼科雜誌
국제안과잡지
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY
2014年
5期
922-924
,共3页
倪双%葛红岩%刘法%金鑫%刘平
倪雙%葛紅巖%劉法%金鑫%劉平
예쌍%갈홍암%류법%금흠%류평
穿透性角膜移植%角膜免疫排斥
穿透性角膜移植%角膜免疫排斥
천투성각막이식%각막면역배척
penetrating keratoplasty%corneal immune rejection
目的:探讨穿透性角膜移植的主要病因、疗效及并发症。<br> 方法:回顾性分析2011-01/2013-06于我院行穿透性角膜移植术的患者150例150眼。<br> 结果:病因:角膜白斑99眼(66%),角膜变性18眼(12%),角膜溃疡15眼(10%),角膜内皮失代偿10眼(6.7%),圆锥角膜8眼(5.3%)。疗效:植片透明110例(73.3%)。视力≤0.05者42例(28%),0.05<视力≤0.3者60例(40%),视力>0.3者48例(32%)。并发症:主要并发症为免疫排斥反应28例(18.7%)。<br> 结论:穿透性角膜移植是治疗角膜疾病致盲的重要有效手段,但术后排斥反应仍是影响手术成功的主要因素。
目的:探討穿透性角膜移植的主要病因、療效及併髮癥。<br> 方法:迴顧性分析2011-01/2013-06于我院行穿透性角膜移植術的患者150例150眼。<br> 結果:病因:角膜白斑99眼(66%),角膜變性18眼(12%),角膜潰瘍15眼(10%),角膜內皮失代償10眼(6.7%),圓錐角膜8眼(5.3%)。療效:植片透明110例(73.3%)。視力≤0.05者42例(28%),0.05<視力≤0.3者60例(40%),視力>0.3者48例(32%)。併髮癥:主要併髮癥為免疫排斥反應28例(18.7%)。<br> 結論:穿透性角膜移植是治療角膜疾病緻盲的重要有效手段,但術後排斥反應仍是影響手術成功的主要因素。
목적:탐토천투성각막이식적주요병인、료효급병발증。<br> 방법:회고성분석2011-01/2013-06우아원행천투성각막이식술적환자150례150안。<br> 결과:병인:각막백반99안(66%),각막변성18안(12%),각막궤양15안(10%),각막내피실대상10안(6.7%),원추각막8안(5.3%)。료효:식편투명110례(73.3%)。시력≤0.05자42례(28%),0.05<시력≤0.3자60례(40%),시력>0.3자48례(32%)。병발증:주요병발증위면역배척반응28례(18.7%)。<br> 결론:천투성각막이식시치료각막질병치맹적중요유효수단,단술후배척반응잉시영향수술성공적주요인소。
AIM: To investigate the main reasons, effects and complications of penetrating keratoplasty. <br> METHOTS: Retrospective analysis on 150 cases ( 150 eyes) of penetrating keratoplasty was done from Jan. 2011 to June 2013. <br> RESULTS: Reasons: coneal lecuma 99 eyes ( 66%);corneal degeneration 18 eyes ( 12%); corneal ulcers 15 eyes ( 10%); corneal endothelium decompensation 10 eyes (6. 7%);keratoconus 8 eyes (5. 3%). Effects:Grafts were transparent in 110 eyes (73. 3%). There are 42 eyes (28%) less than or equal to 0. 05 in visual acuity,60 eyes (40%) better than 0. 05 and less than or equal to 0. 3 and 48 eyes (32%) better than 0. 3. Complication: The main complication was immune rejection (28 eyes, 18. 7%). <br> CONCLUSION:Penetrating keratoplasty is an important and effective means for keratitis disease.